Impact of cilostazol administration on femoropopliteal in-stent restenosis
Y Tomoi, Y Soga, O Iida, M Fujihara… - Journal of …, 2017 - journals.sagepub.com
Purpose: To investigate whether administering cilostazol after treatment for femoropopliteal
in-stent restenosis (ISR) can have a positive impact on recurrent ISR (Re-ISR). Methods: The
database of a multicenter, retrospective, observational registry was interrogated to identify
338 consecutive patients (mean age 72.3±8.8 years; 148 men) who underwent
endovascular therapy for femoropopliteal ISR in 379 limbs from January 2010 to December
2014. Ninety-seven patients (103 limbs) who received cilostazol after the initial stent …
in-stent restenosis (ISR) can have a positive impact on recurrent ISR (Re-ISR). Methods: The
database of a multicenter, retrospective, observational registry was interrogated to identify
338 consecutive patients (mean age 72.3±8.8 years; 148 men) who underwent
endovascular therapy for femoropopliteal ISR in 379 limbs from January 2010 to December
2014. Ninety-seven patients (103 limbs) who received cilostazol after the initial stent …
以上显示的是最相近的搜索结果。 查看全部搜索结果